Clinical Trial Update: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating administration of T lymphocytes to prevent relapse in Hodgkin lymphoma and other lymphomas; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• T lymphocyte therapy (adoptive T cell therapy)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Hodgkin Disease, Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-15